| 09.00 – 10.00 |
The Society for Endocrinology
Medal Lecture Great Hall |
| |
|
Chair: John Wass (Oxford) |
 |
| S3 |
|
Hormone
action - insights from human genetic disorders |
| |
|
Krish Chatterjee (Cambridge) |
|
| 10.00 – 10.30 |
Coffee Great Hall and Small Hall Foyers |
|
| 10.30– 12.30 |
Symposium 5: |
| |
|
Sexual differentiation |
| |
|
Chair: Caroline Brain (London) |
|
| S21 |
|
Update
on genetic mechanisms of sex determination |
| |
|
Robin Lovell-Badge (London) |
|
| S22 |
|
Molecular
and phenotypic features of disorders of sex development (DSD) in humans |
| |
|
John Achermann (London) |
|
| S23 |
|
Management
of disorders of sex development |
| |
|
Peter Clayton (Manchester) |
|
| 10.30 – 12.30 |
Oral Communications 2 Small
Hall
Placenta, bone and genetics
Chairs: A White (Manchester) & R Andrew (Edinburgh) |
|
| OC9 |
|
IGF
acts through the IGF1R mediated PI3K pathway in first trimester human placenta
to rescue cytotrophoblasts from apoptosis |
| |
|
K Forbes, J Aplin, M Westwood |
|
| OC10 |
|
The
expression and regulation of the tachykinin (TAC) genes in the placenta |
| |
|
N Page, J Dakour, D Morrish |
|
| OC11 |
|
Effect
of leptin on hepatic carbohydrate metabolism and insulin signalling proteins
in fetal sheep |
| |
|
A Forhead, C Lamb, K Franko, R Cripps, S Ozanne, D Blache,
A Fowden |
|
| OC12 |
|
Physiological
blockade of gut hormones increases food intake |
| |
|
A Kokkinos, R Vincent, C le Roux,M Ghatei, S Bloom |
|
| OC13 |
|
A
kindred with Carney Complex due to a novel PRKAR1A gene mutation (c1067_1070
del AACG ins GCCCA) |
| |
|
C Strey, J Randall, S Conroy,A Horvath, P Weissberg, L
Berman, A Dixon, G Hoffman, J Cooper, H Firth, D Wood, H Simpson, K Chatterjee,
C Stratakis, A Melvin, M Gurnell |
|
| OC14 |
|
The
metabolic basis of a severe rickets-like deformity in Nigerian children |
| |
|
O Couppis,W Emmert, K Kitz, W Van't Hoff, W Drake, Stich |
|
| OC15 |
|
Preliminary
results from the PRISM study: a multicentre randomised controlled trial
of intensive vs. symptomatic management for Paget's disease of bone |
| |
|
S Ralston, A Langston, M Campbell, G MacLennan, P Selby,W
Fraser |
|
| OC16 |
|
Symptomatic
improvement after parathyroidectomy for primary hyperparathyroidism |
| |
|
R Mihai, G Sadler |
|
| 10.30– 12.30 |
Symposium 6: Council
Chamber |
| |
|
AMPK systems |
| |
|
Chairs: Marta Korbonits (London) & Ashley Grossman (London) |
|
| S24 |
|
AMPK
cascade - new players upstream and downstream |
| |
|
Ian Salt (Glasgow) |
|
| S25 |
|
AMPK
in the heart - regulation of energy status |
| |
|
Gary Lopaschuk (Edmonton, Canada) |
|
| S26 |
|
Central
and peripheral effects of leptin on AMP-activated protein kinase |
| |
|
Yasuhiko Minokoshi (Okazaki, Japan) |
|
| S27 |
|
Role
of AMP-activated kinase in the control of insulin secretion and satietyof
AMPK in beta-cell function |
| |
|
Guy Rutter (Bristol) |
|
| 12.30 – 13.15 |
Lunch Great Hall and Small Hall Foyers |
|
| 12.30 – 13.15 |
Attended Posters
Lower Foyer |
|
| 13.15 – 14.15 |
Clinical debate Great Hall |
| |
|
'This house believes that biochemical monitoring of hydrocortisone
replacement therapy in Addison's disease is a waste of time' |
| |
|
Chair: S Atkin (Hull) |
|
| |
|
For: Richard Ross (Sheffield) |
| |
|
Against: Trevor Howlett (Leicester) |
|
| 14.15 – 15.15 |
European Medal Lecture
Great Hall |
| |
|
Chair: John Wass (Oxford) |
|
| S4 |
|
Assessment
of growth hormone levels: tailor-made assays for specific clinical questions |
| |
|
Christian Strasburger (Berlin, Germany) |
|
| 15.15– 15.30 |
Tea Great Hall and Small Hall Foyers |
|
| 15.30 – 17.30 |
Symposium 7 Great
Hall |
| |
|
Controlling the overactive parathyroid |
| |
|
Chair: Peter Selby (Manchester) |
|
| S28 |
|
Consequences
of primary and secondary parathyroid overactivity |
| |
|
David Hosking (Nottingham) |
|
| S29 |
|
Medical
management of secondary hyperparathyroidism - lessons from renal disease |
| |
|
John Cunningham (London) |
|
| S30 |
|
Medical
management of primary hyperparathyroidism (PHP) |
| |
|
Munro Peacock (Indiana, USA) |
|
| S31 |
|
Advances
in the surgical management of hyperparathyroidism |
| |
|
Barney Harrison (Sheffield) |
|
| 15.30 – 17.30 |
Oral Communications 3
Small Hall
Pituitary, ovary and steroids
Chairs: C McCabe (Birmingham)& D Ray (Manchester) |
|
|
| OC17 |
|
Prolactinomas:
All in the family? |
| |
|
S Razvi, S Ashwell, M Korbonits, R Quinton, R Quinton |
|
| OC18 |
|
Adult
onset diabetes insipidus due to congenital midline defects of the brain
|
| |
|
S Zachariah, S Hyer |
|
| OC19 |
|
Metformin
stimulates AMP kinase activity and increases lactate production in human
granulosa cells |
| |
|
M Richardson, R Sreekumar, L Sellahewa, S Ingamells, I
Cameron, C Byrne |
|
| OC20 |
|
Novel
activation of MAPK family proteins in pituitary GH3 somatotrophs and alphaT3-1
gonadotrophs by C-type natriuretic peptide (CNP) |
| |
|
K Jonas, I Thompson,A Chand, R Fowkes |
|
| OC21 |
|
Macroprolactinoma
with progressive resistance to high-dose cabergoline |
| |
|
C Arun, D Mitra, S Ball, J Hill, J Lewis, R Quinton |
|
| OC22 |
|
Coupling
of cell cycle progression to GR cellular distribution |
| |
|
L Matthews, D Spiller, C Rivers,M Norman, M White, D Ray |
|
| OC23 |
|
Metformin
inhibits ovarian aromatase and anti-Müllerian hormone (AMH) production |
| |
|
S Rice, L Pellatt, D Feldman, P Malloy, S Whitehead, H
Mason |
|
| OC24 |
|
Influence
of C-type natriuretic peptide (CNP) on cell proliferation in alphaT3-1
gonadotrophs and GH3 somatotrophs |
| |
|
I Thompson, K Jonas, S Wolf, C Lawson, C Wheeler-Jones,
R Fowkes |
|
| 15.30 – 17.30 |
Symposium 8 Council
Chamber |
| |
|
Adipocyte and insulin resistance |
| |
|
Chair: Steve Atkin (Hull) & R Semple (Cambridge) |
|
| S32 |
|
Adipose
tissue and fatty acids as precursors to insulin resistance |
| |
|
Keith Frayn (Oxford) |
|
| S33 |
|
What
role for adipocytokines in insulin resistance and diabetes prediction? From
genes to epidemiology |
| |
|
Naveed Sattar (Glasgow) |
|
| S34 |
|
The
ins and outs of steroid hormones in adipose tissue |
| |
|
Brian Walker (Edinburgh) |
|
| S35 |
|
Fat
mobilisation with insulin sensitising agents: what clues to mechanisms? |
| |
|
James Tobin (Cambridge, USA) |
|